
Understanding Prescription Weight Loss Medications
FDA-approved weight management medications hit the market as an innovative obesity treatment in 2021, and have saturated the public conscience ever since.
How do they work? By mimicking the hormones in your body that naturally tell you when you’re full or hungry (GLP-1), the medication takes on the role of regulating appetite, insulin levels, and digestion. You can expect slower digestion, increased feelings of fullness, and reduced cravings — all of which contribute to a lower calorie intake over time.
At Lifestyle Med Spa, we specialize in GLP-1 and GLP-1/GIP medications. Here are some of the differences:
- GLP-1 Medications: GLP-1 Agonists like Ozempic and Wegovy only target the GLP-1 receptor, without the added effects of GIP receptor activation. Studies show patients losing an average of around 14.9% of their body weight in clinical trials.
- GLP-1/GIP Medications: Dual Agonists like Mounjaro and Zepbound that activate both GIP and GLP-1 receptors. In studies, patients experienced a 15-22% reduction in body weight, exceeding what is typically seen with GLP-1 agonists alone.